Active, not recruitingPHASE1, PHASE2NCT05121376
A Gene Therapy Study of BMN 331 in Subjects With Hereditary Angioedema
Studying Hereditary angioedema
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- BioMarin Pharmaceutical
- Principal Investigator
- MD Medical DirectorBioMarin Pharmaceutical
- Intervention
- Dose 1 of BMN 331(genetic)
- Enrollment
- 44 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2022 – 2028
Study locations (16)
- AllerVie Clinical Research, Birmingham, Alabama, United States
- Medical Research of Arizona, Scottsdale, Arizona, United States
- University of California San Diego, San Diego, California, United States
- Asthma & Allergy Associates P.C., Colorado Springs, Colorado, United States
- Dr. Henry J. Kanarek Allergy, Asthma & Immunology, Overland Park, Kansas, United States
- Institute For Asthma & Allergy, Chevy Chase, Maryland, United States
- Mississippi Center for Advanced Medicine, Madison, Mississippi, United States
- Washington University School of Medicine, St Louis, Missouri, United States
- Duke Health, Durham, North Carolina, United States
- University of Cincinnati (UC) Physicians Company, LLC, Cincinnati, Ohio, United States
- Optimed Research, LTD, Columbus, Ohio, United States
- The Pennsylvania State University (Penn State) Milton S. Hershey Medical Center, Hershey, Pennsylvania, United States
- AARA Research Center, Dallas, Texas, United States
- Royal Prince Alfred Hospital,, Camperdown, Australia
- Hospital Universitario Vall d'Hebron, Barcelona, Spain
- +1 more locations on ClinicalTrials.gov
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT05121376 on ClinicalTrials.govOther trials for Hereditary angioedema
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE3NCT07298447Donidalorsen Treatment in Children With Hereditary AngioedemaIonis Pharmaceuticals, Inc.
- RECRUITINGNANCT07559630Single-center Randomized Controlled Trial of Rectal Arterial Embolization vs Band Ligation for the Treatment of Internal hemOrrhoidSJessica K. Stewart, MD
- RECRUITINGPHASE3NCT07428499Phase 3 Extension Study of ADX-324 in Participants With Hereditary Angioedema (HAE)ADARx Pharmaceuticals, Inc.
- RECRUITINGNANCT07251933A Study of Lanadelumab in Children With Hereditary Angioedema (HAE) in Multiple CountriesTakeda
- ENROLLING BY INVITATIONPHASE3NCT07204938A Long-Term Study of Navenibart in Participants With Hereditary AngioedemaAstria Therapeutics, Inc.
- RECRUITINGPHASE3NCT06960213STOP-HAE: A Phase 3 Study of ADX-324 in HAEADARx Pharmaceuticals, Inc.
- RECRUITINGNANCT07001280A Study Investigating the Effectiveness and Safety of Garadacimab for Treating Patients With Hereditary Angioedema (HAE)CSL Behring
- RECRUITINGPHASE3NCT06842823A Study of Navenibart in Participants With Hereditary AngioedemaAstria Therapeutics, Inc.